Cerity Partners’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Buy
+6,784
New +$205K ﹤0.01% 2961
2025
Q2
– Sell
-21,138
Closed -$423K – 2659
2025
Q1
$423K Buy
+21,138
New +$523K ﹤0.01% 1860

Other funds holding CSTL

Cerity Partners's CSTL Position: Q3 2026 in Review

Cerity Partners opened a new position in Castle Biosciences (CSTL) in Q3 2026: 6,784 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2961 among its holdings. This is a return to the name: Cerity Partners previously reported a position in CSTL as recently as Q1 2025.

Cerity Partners first reported a position in CSTL in Q1 2025 and has held it in 2 quarters since. The position peaked at $423K in Q1 2025. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Cerity Partners held 6,784 shares of Castle Biosciences worth $241K as of Q3 2026.
  • Castle Biosciences was a new Cerity Partners position in Q3 2026.
  • Castle Biosciences made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2961 holding.
  • Cerity Partners first reported a position in Castle Biosciences in Q1 2025 and has held it in 2 quarters since.
  • Cerity Partners's Castle Biosciences position peaked at $423K in Q1 2025.
  • 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.